Tax Court Backs Medtronic In Transfer-Payment Dispute
This article was originally published in The Gray Sheet
The ruling means a larger portion of the company’s earnings can be taxed at the lower rate applied to foreign corporations.
You may also be interested in...
Boston Sci plans to pay $275m to settle transfer-pricing disputes with the US Internal Revenue Service. A financial analyst views the settlement as a win for the company because it’s well below what the IRS initially sought.
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.